Schedule 13G ownership disclosure

Arcus Biosciences Inc

Common Stock, par value $0.0001 per share · CUSIP: 03969F109

Event date: 2025-05-12

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 5,831,099.00 · Class: 5.5%

  • Point72 Capital Advisors, Inc.

    Shares: 5,831,099.00 · Class: 5.5%

  • Steven A. Cohen

    Shares: 5,831,099.00 · Class: 5.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-002303
Form type
SCHEDULE 13G
Filer
Arcus Biosciences, Inc.
CIK
CIK 1724521
Filed
May 13, 2025
Reporting period
May 12, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SCHEDULE 13G | SEC Filings Hub